A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women with Low Bone MasS (ARTEMIS)

Recruiting

Phase 2

AGA2118A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women with Low Bone MasS (ARTEMIS)

Sponsor:

Angitia Biopharmaceuticals

Code:

NCT06577935

Conditions

Postmenopausal Osteoporosis

Eligibility Criteria

Sex: Female

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

AGA2118

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Angitia Biopharmaceuticals on 2025-03-25.